Aerie Pharmaceuticals Inc (AERI)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Rajkumar Kannan |
| Employees: | 380 |
| Web site: | aeriepharma.com |
|
4301 EMPEROR BOULEVARD, SUITE 400, DURHAM, NC, 27703
(919) 237-5300
| |
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Aerie Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) and Rocklatan. The company also develops AR-15512 to treat signs and symptoms of dry eye.
Please log in first to see chart